Ovation Science Inc. (OVATF)
Ovation Science Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $288,313. On trailing twelve-month figures it carries a trailing P/E of -1.76, a net margin of -934.2%. Its beta of 0.73 implies it has historically moved less than the broad market.
Ovation Science Inc. specializes in the manufacturing of cannabis and hemp-derived products, distributing them across Canada, the United States, and Mexico. Central to its operations is Invisicare, a proprietary, patented drug delivery system. This advanced technology is incorporated into topical and transdermal skincare products, which feature hemp seed oil and cannabis, and are marketed under the Ovation and BASKiN brands. Beyond this core technology, the company offers a range of other solutions: health and wellness products infused with cannabidiol (CBD) under the Invibe MD name, CBD-focused skincare solutions branded as ARLO CBD, and hand sanitizers known as DermSafe. Furthermore, Ovation Science Inc. possesses various sublicenses for cannabis-related offerings and oversees the Lighthouse platform, which caters to licensed dispensaries throughout the United States. The firm was established in 2017 and maintains its primary corporate offices in Vancouver, Canada.
Ovation Science Inc. is most often compared with the following Healthcare names: